Breaking News Instant updates and real-time market news.

PRSO

Peraso

$1.55 /

+ (+0.00%)

09:17
10/25/22
10/25
09:17
10/25/22
09:17

Peraso names Mark Lunsford Chief Revenue Officer

Peraso announced that it has named Mark Lunsford to the position of Chief Revenue Officer. Lunsford will be responsible for sales, business development and strategic partnership efforts."Mark brings a deep understanding of leading-edge technologies and has demonstrated success across companies at various stages of growth," said Ron Glibbery, CEO of Peraso.

  • 25

    Oct

  • 01

    Dec

OTHER BREAKING NEWS FROM THE FLY

Syndicate
Iveric bio 13.35M share Spot Secondary priced at $22.50 » 06:12
12/01/22
12/01
06:12
12/01/22
06:12
ISEE

Iveric bio

$23.60 /

+0.77 (+3.37%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ISEE Iveric bio
$23.60 /

+0.77 (+3.37%)

ISEE Iveric bio
$23.60 /

+0.77 (+3.37%)

11/10/22 Jefferies
Apellis downgraded to Hold at Jefferies after doctor survey
11/10/22 Jefferies
Iveric bio downgraded to Hold at Jefferies after doctor survey
11/10/22 Jefferies
Iveric bio downgraded to Hold from Buy at Jefferies
10/17/22 B. Riley
Iveric bio upgraded to Neutral at B. Riley after competitor in GA 'disappoints'
ISEE Iveric bio
$23.60 /

+0.77 (+3.37%)

  • 01
    Dec
ISEE Iveric bio
$23.60 /

+0.77 (+3.37%)

ISEE Iveric bio
$23.60 /

+0.77 (+3.37%)

Initiation
ADT Inc. resumed with a Buy at Citi » 06:11
12/01/22
12/01
06:11
12/01/22
06:11
ADT

ADT Inc.

$9.34 /

+0.135 (+1.47%)

Citi analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADT ADT Inc.
$9.34 /

+0.135 (+1.47%)

ADT ADT Inc.
$9.34 /

+0.135 (+1.47%)

10/31/22 Morgan Stanley
ADT Inc. resumed with an Equal Weight at Morgan Stanley
01/06/22 RBC Capital
ADT Inc. downgraded to Sector Perform at RBC Capital on free cash flow headwinds
01/06/22 RBC Capital
ADT Inc. downgraded to Sector Perform from Outperform at RBC Capital
01/05/22 Citi
ADT Inc. resumed with a Buy at Citi
ADT ADT Inc.
$9.34 /

+0.135 (+1.47%)

ADT ADT Inc.
$9.34 /

+0.135 (+1.47%)

ADT ADT Inc.
$9.34 /

+0.135 (+1.47%)

ADT ADT Inc.
$9.34 /

+0.135 (+1.47%)

Hot Stocks
Bank of Montreal raises quarterly dividend 3% to C$1.43 per share » 06:11
12/01/22
12/01
06:11
12/01/22
06:11
BMO

Bank of Montreal

$97.83 /

+1.73 (+1.80%)

The dividend on the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMO Bank of Montreal
$97.83 /

+1.73 (+1.80%)

BMO Bank of Montreal
$97.83 /

+1.73 (+1.80%)

11/22/22 Scotiabank
Bank of Montreal price target lowered to C$156 from C$159 at Scotiabank
11/18/22 National Bank
Bank of Montreal price target lowered to C$147 from C$151 at National Bank
09/01/22 Desjardins
Bank of Montreal price target lowered to C$150 from C$153 at Desjardins
09/01/22 Canaccord
Bank of Montreal price target lowered to C$150.50 from C$152.50 at Canaccord
BMO Bank of Montreal
$97.83 /

+1.73 (+1.80%)

BMO Bank of Montreal
$97.83 /

+1.73 (+1.80%)

Recommendations
Okta price target lowered to $85 from $95 at Oppenheimer » 06:11
12/01/22
12/01
06:11
12/01/22
06:11
OKTA

Okta

$53.31 /

+2.06 (+4.02%)

Oppenheimer analyst Ittai…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OKTA Okta
$53.31 /

+2.06 (+4.02%)

OKTA Okta
$53.31 /

+2.06 (+4.02%)

11/29/22 Jefferies
Okta risk/reward attractive amid low expectations, says Jefferies
11/22/22 Piper Sandler
Okta price target lowered to $80 from $125 at Piper Sandler
11/14/22 Canaccord
Okta price target lowered to $70 from $85 at Canaccord
11/14/22 JMP Securities
Okta price target lowered to $105 from $145 at JMP Securities
OKTA Okta
$53.31 /

+2.06 (+4.02%)

OKTA Okta
$53.31 /

+2.06 (+4.02%)

OKTA Okta
$53.31 /

+2.06 (+4.02%)

OKTA Okta
$53.31 /

+2.06 (+4.02%)

Earnings
Bank of Montreal reports Q4 adjusted EPS C$3.04 vs. C$3.33 a year ago » 06:10
12/01/22
12/01
06:10
12/01/22
06:10
BMO

Bank of Montreal

$97.83 /

+1.73 (+1.80%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMO Bank of Montreal
$97.83 /

+1.73 (+1.80%)

BMO Bank of Montreal
$97.83 /

+1.73 (+1.80%)

11/22/22 Scotiabank
Bank of Montreal price target lowered to C$156 from C$159 at Scotiabank
11/18/22 National Bank
Bank of Montreal price target lowered to C$147 from C$151 at National Bank
09/01/22 Desjardins
Bank of Montreal price target lowered to C$150 from C$153 at Desjardins
09/01/22 Canaccord
Bank of Montreal price target lowered to C$150.50 from C$152.50 at Canaccord
BMO Bank of Montreal
$97.83 /

+1.73 (+1.80%)

BMO Bank of Montreal
$97.83 /

+1.73 (+1.80%)

Syndicate
Intellia Therapeutics 6.55M share Spot Secondary priced at $45.80 » 06:10
12/01/22
12/01
06:10
12/01/22
06:10
NTLA

Intellia Therapeutics

$51.41 /

+3.44 (+7.17%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

11/14/22 Chardan
Intellia Therapeutics price target raised to $129 from $121 at Chardan
11/03/22 Chardan
Intellia Therapeutics price target lowered to $121 from $146 at Chardan
10/31/22 EF Hutton
Intellia Therapeutics initiated with a Buy at EF Hutton
10/11/22 Morgan Stanley
Intellia Therapeutics initiated with an Overweight at Morgan Stanley
NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

  • 01
    Dec
NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

Recommendations
Elastic price target lowered to $90 from $110 at Oppenheimer » 06:10
12/01/22
12/01
06:10
12/01/22
06:10
ESTC

Elastic

$61.16 /

+2.16 (+3.66%)

Oppenheimer analyst Ittai…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ESTC Elastic
$61.16 /

+2.16 (+3.66%)

ESTC Elastic
$61.16 /

+2.16 (+3.66%)

11/18/22 Barclays
Elastic price target lowered to $80 from $85 at Barclays
10/26/22 Truist
Elastic price target lowered to $95 from $105 at Truist
10/19/22 Baird
Elastic assumed with an Outperform at Baird
10/18/22 Barclays
Elastic price target lowered to $85 from $105 at Barclays
ESTC Elastic
$61.16 /

+2.16 (+3.66%)

ESTC Elastic
$61.16 /

+2.16 (+3.66%)

ESTC Elastic
$61.16 /

+2.16 (+3.66%)

Hot Stocks
Wallbox appoints new Chief Communications and Public Affairs Officer, CMO » 06:10
12/01/22
12/01
06:10
12/01/22
06:10
WBX

Wallbox

$5.59 /

+0.24 (+4.49%)

Wallbox announced two…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WBX Wallbox
$5.59 /

+0.24 (+4.49%)

WBX Wallbox
$5.59 /

+0.24 (+4.49%)

11/22/22 Northland
Wallbox initiated with an Outperform at Northland
11/10/22 Canaccord
Wallbox price target lowered to $13 from $14 at Canaccord
11/10/22 Baird
Wallbox price target lowered to $14 from $20 at Baird
09/07/22 Credit Suisse
Wallbox initiated with an Outperform at Credit Suisse
WBX Wallbox
$5.59 /

+0.24 (+4.49%)

Recommendations
Portage Biotech price target lowered to $21 from $22 at H.C. Wainwright » 06:09
12/01/22
12/01
06:09
12/01/22
06:09
PRTG

Portage Biotech

$5.75 /

-0.15 (-2.54%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRTG Portage Biotech
$5.75 /

-0.15 (-2.54%)

PRTG Portage Biotech
$5.75 /

-0.15 (-2.54%)

11/30/22 Cantor Fitzgerald
Portage Biotech price target lowered to $18 from $26 at Cantor Fitzgerald
11/30/22 Oppenheimer
Portage Biotech price target lowered to $18 from $26 at Oppenheimer
09/20/22 H.C. Wainwright
Portage Biotech price target lowered to $22 from $32 at H.C. Wainwright
07/15/22 Oppenheimer
Portage Biotech assumed with an Outperform at Oppenheimer
PRTG Portage Biotech
$5.75 /

-0.15 (-2.54%)

PRTG Portage Biotech
$5.75 /

-0.15 (-2.54%)

PRTG Portage Biotech
$5.75 /

-0.15 (-2.54%)

Initiation
Viridian Therapeutics initiated with a Buy at H.C. Wainwright » 06:09
12/01/22
12/01
06:09
12/01/22
06:09
VRDN

Viridian Therapeutics

$25.22 /

+2.37 (+10.37%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRDN Viridian Therapeutics
$25.22 /

+2.37 (+10.37%)

VRDN Viridian Therapeutics
$25.22 /

+2.37 (+10.37%)

10/14/22 Evercore ISI
Viridian Therapeutics added to 'TAP Outperform' list at Evercore ISI
08/16/22 B. Riley
Viridian Therapeutics price target raised to $40 from $25 at B. Riley
08/15/22 Evercore ISI
Viridian Therapeutics price target raised to $50 from $40 at Evercore ISI
06/23/22 B. Riley
B. Riley starts Viridian Therapeutics at Buy with $25 price target
VRDN Viridian Therapeutics
$25.22 /

+2.37 (+10.37%)

  • 17
    Aug
VRDN Viridian Therapeutics
$25.22 /

+2.37 (+10.37%)

Hot Stocks
Sempra Energy subsidiary enters SPA with Ineos for LNG supply » 06:08
12/01/22
12/01
06:08
12/01/22
06:08
SRE

Sempra Energy

$166.28 /

+4.865 (+3.01%)

Sempra Infrastructure, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRE Sempra Energy
$166.28 /

+4.865 (+3.01%)

SRE Sempra Energy
$166.28 /

+4.865 (+3.01%)

10/24/22 Guggenheim
Sempra Energy price target lowered to $165 from $174 at Guggenheim
10/03/22 Mizuho
Sempra Energy price target lowered to $161 from $173 at Mizuho
09/15/22 Wells Fargo
Sempra Energy price target raised to $189 from $184 at Wells Fargo
07/18/22 Barclays
Sempra Energy price target lowered to $176 from $186 at Barclays
SRE Sempra Energy
$166.28 /

+4.865 (+3.01%)

SRE Sempra Energy
$166.28 /

+4.865 (+3.01%)

SRE Sempra Energy
$166.28 /

+4.865 (+3.01%)

Downgrade
Allianz downgraded to Neutral from Outperform at Exane BNP Paribas » 06:08
12/01/22
12/01
06:08
12/01/22
06:08
ALIZY

Allianz

$21.35 /

+0.13 (+0.61%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALIZY Allianz
$21.35 /

+0.13 (+0.61%)

ALIZY Allianz
$21.35 /

+0.13 (+0.61%)

11/14/22 Berenberg
Allianz price target raised to EUR 271 from EUR 267 at Berenberg
11/11/22 JPMorgan
Allianz price target raised to EUR 220 from EUR 210 at JPMorgan
10/21/22 Barclays
Allianz price target lowered to EUR 205 from EUR 214 at Barclays
10/19/22 JPMorgan
Allianz price target lowered to EUR 210 from EUR 220 at JPMorgan
Downgrade
SQZ Biotechnologies downgraded to Underperform from Buy at BofA » 06:08
12/01/22
12/01
06:08
12/01/22
06:08
SQZ

SQZ Biotechnologies

$2.51 /

+0.02 (+0.80%)

BofA analyst Tazeen Ahmad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SQZ SQZ Biotechnologies
$2.51 /

+0.02 (+0.80%)

SQZ SQZ Biotechnologies
$2.51 /

+0.02 (+0.80%)

10/20/22 H.C. Wainwright
SQZ Biotechnologies initiated with a Buy at H.C. Wainwright
10/06/22 BTIG
SQZ Biotechnologies price target lowered to $15 from $40 at BTIG
05/25/22 Chardan
SQZ Biotechnologies initiated with Buy, $17 target at Chardan
05/25/22 Chardan
SQZ Biotechnologies initiated with a Buy at Chardan
SQZ SQZ Biotechnologies
$2.51 /

+0.02 (+0.80%)

Initiation
Sapiens initiated with an Underweight at JPMorgan » 06:06
12/01/22
12/01
06:06
12/01/22
06:06
SPNS

Sapiens

$19.46 /

+0.21 (+1.09%)

JPMorgan analyst Alexei…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPNS Sapiens
$19.46 /

+0.21 (+1.09%)

SPNS Sapiens
$19.46 /

+0.21 (+1.09%)

08/08/22 Citi
Sapiens price target lowered to $25 from $27 at Citi
02/24/22 Citi
Sapiens price target lowered to $30 from $38 at Citi
12/14/21 JPMorgan
Sapiens downgraded to Underweight from Neutral at JPMorgan
12/14/21 JPMorgan
Sapiens downgraded to Underweight from Neutral at JPMorgan
SPNS Sapiens
$19.46 /

+0.21 (+1.09%)

Downgrade
Zebra Technologies downgraded to Underperform from Peer Perform at Wolfe Research » 06:06
12/01/22
12/01
06:06
12/01/22
06:06
ZBRA

Zebra Technologies

$270.15 /

+3.36 (+1.26%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZBRA Zebra Technologies
$270.15 /

+3.36 (+1.26%)

ZBRA Zebra Technologies
$270.15 /

+3.36 (+1.26%)

11/03/22 UBS
Zebra Technologies price target lowered to $445 from $485 at UBS
11/02/22 Needham
Zebra Technologies price target lowered to $330 from $450 at Needham
11/02/22 Baird
Zebra Technologies price target lowered to $300 from $330 at Baird
10/14/22 Morgan Stanley
Zebra Technologies price target lowered to $225 from $335 at Morgan Stanley
ZBRA Zebra Technologies
$270.15 /

+3.36 (+1.26%)

Hot Stocks
Big Lots sees Q4 comparable store sales down in low double-digit range » 06:06
12/01/22
12/01
06:06
12/01/22
06:06
BIG

Big Lots

$19.49 /

+0.275 (+1.43%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIG Big Lots
$19.49 /

+0.275 (+1.43%)

BIG Big Lots
$19.49 /

+0.275 (+1.43%)

11/29/22 Deutsche Bank
Big Lots price target lowered to $13 from $18 at Deutsche Bank
09/16/22 JPMorgan
Big Lots price target raised to $9 from $8 at JPMorgan
08/24/22 Deutsche Bank
Big Lots price target lowered to $18 from $23 at Deutsche Bank
06/21/22 Loop Capital
Big Lots price target lowered to $22 from $27 at Loop Capital
BIG Big Lots
$19.49 /

+0.275 (+1.43%)

BIG Big Lots
$19.49 /

+0.275 (+1.43%)

BIG Big Lots
$19.49 /

+0.275 (+1.43%)

Initiation
SpringsWorks Therapeutics initiated with a Buy at BofA » 06:06
12/01/22
12/01
06:06
12/01/22
06:06
SWTX

SpringsWorks Therapeutics

$24.16 /

+0.72 (+3.07%)

BofA analyst Alec…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SWTX SpringsWorks Therapeutics
$24.16 /

+0.72 (+3.07%)

SWTX SpringsWorks Therapeutics
$24.16 /

+0.72 (+3.07%)

09/12/22 H.C. Wainwright
SpringsWorks price target raised to $103 from $94 at H.C. Wainwright
08/09/22 H.C. Wainwright
SpringsWorks Therapeutics price target lowered to $94 from $95 at H.C. Wainwright
06/06/22 H.C. Wainwright
SpringsWorks price target lowered to $95 from $142 at H.C. Wainwright
06/06/22 H.C. Wainwright
Turning Point Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
SWTX SpringsWorks Therapeutics
$24.16 /

+0.72 (+3.07%)

SWTX SpringsWorks Therapeutics
$24.16 /

+0.72 (+3.07%)

Initiation
Day One Biopharmaceuticals initiated with a Buy at BofA » 06:05
12/01/22
12/01
06:05
12/01/22
06:05
DAWN

Day One Biopharmaceuticals

$21.20 /

+0.85 (+4.18%)

BofA analyst Alec…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DAWN Day One Biopharmaceuticals
$21.20 /

+0.85 (+4.18%)

DAWN Day One Biopharmaceuticals
$21.20 /

+0.85 (+4.18%)

06/20/22 Piper Sandler
Day One Biopharmaceuticals price target raised to $40 from $35 at Piper Sandler
06/13/22 Wedbush
Day One Biopharmaceuticals price target raised to $35 from $32 at Wedbush
06/13/22 Piper Sandler
Piper reiterates $35 target on Day One after 'new high mark' data
06/13/22 JPMorgan
JPMorgan sees Day One shares moving to mid-teens, low-$20s on data
DAWN Day One Biopharmaceuticals
$21.20 /

+0.85 (+4.18%)

  • 15
    Jun
DAWN Day One Biopharmaceuticals
$21.20 /

+0.85 (+4.18%)

DAWN Day One Biopharmaceuticals
$21.20 /

+0.85 (+4.18%)

Upgrade
Vertiv Holdings upgraded to Outperform from Peer Perform at Wolfe Research » 06:05
12/01/22
12/01
06:05
12/01/22
06:05
VRT

Vertiv Holdings

$13.87 /

+0.68 (+5.16%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRT Vertiv Holdings
$13.87 /

+0.68 (+5.16%)

VRT Vertiv Holdings
$13.87 /

+0.68 (+5.16%)

10/27/22 Deutsche Bank
Vertiv Holdings price target raised to $17 from $15 at Deutsche Bank
10/27/22 Cowen
Vertiv Holdings upgraded to Outperform from Market Perform at Cowen
10/04/22 Deutsche Bank
Vertiv Holdings price target lowered to $15 from $16 at Deutsche Bank
09/23/22 Cowen
Vertiv Holdings price target lowered to $11.75 from $12.75 at Cowen
VRT Vertiv Holdings
$13.87 /

+0.68 (+5.16%)

VRT Vertiv Holdings
$13.87 /

+0.68 (+5.16%)

VRT Vertiv Holdings
$13.87 /

+0.68 (+5.16%)

Initiation
Duck Creek Technologies initiated with a Neutral at JPMorgan » 06:04
12/01/22
12/01
06:04
12/01/22
06:04
DCT

Duck Creek Technologies

$11.17 /

+0.365 (+3.38%)

JPMorgan analyst Alexei…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DCT Duck Creek Technologies
$11.17 /

+0.365 (+3.38%)

DCT Duck Creek Technologies
$11.17 /

+0.365 (+3.38%)

10/13/22 RBC Capital
Duck Creek Technologies price target lowered to $12 from $14 at RBC Capital
10/13/22 Needham
Duck Creek Technologies price target lowered to $16 from $20 at Needham
10/13/22 DA Davidson
Duck Creek Technologies price target lowered to $27 from $30 at DA Davidson
10/12/22 Barclays
Duck Creek price target lowered to $14 from $21 at Barclays
DCT Duck Creek Technologies
$11.17 /

+0.365 (+3.38%)

DCT Duck Creek Technologies
$11.17 /

+0.365 (+3.38%)

Downgrade
Saia downgraded to Underperform from Neutral at BofA » 06:03
12/01/22
12/01
06:03
12/01/22
06:03
SAIA

Saia

$243.09 /

+8.79 (+3.75%)

BofA analyst Ken Hoexter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAIA Saia
$243.09 /

+8.79 (+3.75%)

SAIA Saia
$243.09 /

+8.79 (+3.75%)

11/28/22 Deutsche Bank
Saia price target raised to $296 from $281 at Deutsche Bank
11/17/22 Wolfe Research
Wolfe reshuffles ratings in freight with five downgrades and one upgrade
11/17/22 Wolfe Research
Saia downgraded to Peer Perform from Outperform at Wolfe Research
11/14/22 Deutsche Bank
Saia price target raised to $281 from $245 at Deutsche Bank
SAIA Saia
$243.09 /

+8.79 (+3.75%)

SAIA Saia
$243.09 /

+8.79 (+3.75%)

Downgrade
Vontier downgraded to Peer Perform from Outperform at Wolfe Research » 06:03
12/01/22
12/01
06:03
12/01/22
06:03
VNT

Vontier

$19.62 /

+0.52 (+2.72%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VNT Vontier
$19.62 /

+0.52 (+2.72%)

VNT Vontier
$19.62 /

+0.52 (+2.72%)

10/10/22 Citi
Vontier price target lowered to $23 from $29 at Citi
10/03/22 Barclays
Vontier price target lowered to $30 from $33 at Barclays
07/08/22 Barclays
Vontier price target lowered to $33 from $39 at Barclays
04/04/22 Barclays
Vontier price target lowered to $40 from $42 at Barclays
VNT Vontier
$19.62 /

+0.52 (+2.72%)

Earnings
Big Lots reports Q3 adjusted EPS ($2.99), consensus ($2.94) » 06:03
12/01/22
12/01
06:03
12/01/22
06:03
BIG

Big Lots

$19.49 /

+0.275 (+1.43%)

Reports Q3 revenue $1.2B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIG Big Lots
$19.49 /

+0.275 (+1.43%)

BIG Big Lots
$19.49 /

+0.275 (+1.43%)

11/29/22 Deutsche Bank
Big Lots price target lowered to $13 from $18 at Deutsche Bank
09/16/22 JPMorgan
Big Lots price target raised to $9 from $8 at JPMorgan
08/24/22 Deutsche Bank
Big Lots price target lowered to $18 from $23 at Deutsche Bank
06/21/22 Loop Capital
Big Lots price target lowered to $22 from $27 at Loop Capital
BIG Big Lots
$19.49 /

+0.275 (+1.43%)

BIG Big Lots
$19.49 /

+0.275 (+1.43%)

BIG Big Lots
$19.49 /

+0.275 (+1.43%)

Initiation
scPharmaceuticals initiated with an Outperform at Cowen » 06:02
12/01/22
12/01
06:02
12/01/22
06:02
SCPH

scPharmaceuticals

$7.33 /

+0.17 (+2.37%)

Cowen analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SCPH scPharmaceuticals
$7.33 /

+0.17 (+2.37%)

SCPH scPharmaceuticals
$7.33 /

+0.17 (+2.37%)

11/10/22 H.C. Wainwright
scPharmaceuticals price target raised to $18 from $15 at H.C. Wainwright
10/21/22 Jefferies
scPharmaceuticals assumed with a Buy, $14 price target at Jefferies
10/20/22 Jefferies
scPharmaceuticals assumed with a Buy at Jefferies
10/11/22 Maxim
scPharmaceuticals price target raised to $13 from $10 at Maxim
SCPH scPharmaceuticals
$7.33 /

+0.17 (+2.37%)

  • 22
    Nov
SCPH scPharmaceuticals
$7.33 /

+0.17 (+2.37%)

Initiation
Guidewire initiated with an Overweight at JPMorgan » 06:02
12/01/22
12/01
06:02
12/01/22
06:02
GWRE

Guidewire

$59.30 /

+2.37 (+4.16%)

JPMorgan analyst Alexei…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GWRE Guidewire
$59.30 /

+2.37 (+4.16%)

GWRE Guidewire
$59.30 /

+2.37 (+4.16%)

09/12/22 Citi
Guidewire price target lowered to $79 from $88 at Citi
09/08/22 Baird
Guidewire price target lowered to $81 from $99 at Baird
09/07/22 JMP Securities
Guidewire price target lowered to $95 from $110 at JMP Securities
09/07/22 RBC Capital
Guidewire price target lowered to $100 from $125 at RBC Capital
GWRE Guidewire
$59.30 /

+2.37 (+4.16%)

GWRE Guidewire
$59.30 /

+2.37 (+4.16%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.